Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome

被引:107
|
作者
Berneis, Kaspar
Rizzo, Manfredi
Lazzaroni, Veronica
Fruzzetti, Franca
Carmina, Enrico
机构
[1] Univ Palermo, Dept Clin Med & Emerging Dis, I-90139 Palermo, Italy
[2] Univ Zurich Hosp, Clin Endocrinol Diabet & Clin Nutr, CH-8091 Zurich, Switzerland
[3] Univ Pisa, Dept Obstet & Gynecol, I-56100 Pisa, Italy
来源
基金
美国国家科学基金会; 美国国家航空航天局;
关键词
D O I
10.1210/jc.2006-1705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: An altered lipid profile is common in polycystic ovary syndrome ( PCOS) and is usually characterized by increased triglycerides and low high-density lipoprotein (HDL)-cholesterol levels. In the general population, these alterations are often associated with the increase of small low-density lipoproteins ( LDLs) in the so-called "atherogenic lipoprotein phenotype" ( ALP) that determines a further increase of cardiovascular risk. In this study, we evaluated the presence of ALP in the plasma of women with PCOS. Setting: Measurements and analysis of LDL size were performed at the Clinic of Endocrinology, Diabetes, and Clinical Nutrition, University Hospital, Zurich. PCOS patients were recruited at the Department of Clinical Medicine, University of Palermo, and the Department of Obstetrics and Gynecology, University of Pisa. Patients: Thirty patients with PCOS ( hyperandrogenism and chronic anovulation) and 24 matched controls were studied. Anthropometric data, blood glucose, serum insulin lipid profile, and LDL size and subclasses were evaluated. Results: Compared with controls, patients with PCOS had higher plasma concentrations of insulin and triglycerides and lower HDL-cholesterol concentrations but no differences in LDL-cholesterol and total cholesterol. Patients with PCOS had smaller LDL size due to a reduction in LDL subclass I, with a concomitant increase in LDL subclasses III and IV. Fourteen PCOS patients had an increase of smaller LDL particles, and it represented the second most common lipid alteration after decrease in HDL- cholesterol. However, because in this PCOS population hypertriglyceridemia was only present in two patients, complete ALP was relatively uncommon. Conclusions: Increase of type III or type IV LDL subclasses is a common finding in PCOS and represents the second most common lipid alteration after HDL- cholesterol decrease. However, in our PCOS patients, because of relatively low triglyceride levels, complete ALP is uncommon.
引用
收藏
页码:186 / 189
页数:4
相关论文
共 50 条
  • [1] Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome (vol 92, pg 186, 2007)
    Berneis, Kaspar
    Rizzo, Manfredi
    Lazzaroni, Veronica
    Fruzzetti, Franca
    Carmina, Enrico
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02): : 482 - 482
  • [2] Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype
    März, W
    Scharnagl, H
    Abletshauser, C
    Hoffmann, MM
    Berg, A
    Keul, J
    Wieland, H
    Baumstark, MW
    [J]. CIRCULATION, 2001, 103 (15) : 1942 - 1948
  • [3] Low-density lipoproteins heterogeneity in the polycystic ovary syndrome
    Fredenrich, A
    Carre, Y
    Hieronimus, S
    Fenichel, P
    Harter, M
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 308 - 308
  • [4] Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome
    vonEckardstein, S
    vonEckardstein, A
    Bender, HG
    Schulte, H
    Assmann, G
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 1996, 10 (05) : 311 - 318
  • [5] Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors
    Legro, RS
    Blanche, P
    Krauss, RM
    Lobo, RA
    [J]. FERTILITY AND STERILITY, 1999, 72 (06) : 990 - 995
  • [6] Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome
    Kim, J. J.
    Chae, S. J.
    Choi, Y. M.
    Hwang, K. R.
    Song, S. H.
    Yoon, S. H.
    Kim, S. M.
    Ku, S. Y.
    Kim, S. H.
    Kim, J. G.
    Moon, S. Y.
    [J]. HUMAN REPRODUCTION, 2013, 28 (05) : 1354 - 1360
  • [7] Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes
    Rizzo, M.
    Berneis, K.
    Altinova, A. E.
    Toruner, F. B.
    Akturk, M.
    Ayvaz, G.
    Rini, G. B.
    Spinas, G. A.
    Arslan, M.
    [J]. DIABETIC MEDICINE, 2008, 25 (12) : 1406 - 1411
  • [8] Size and Subclasses of Low-Density Lipoproteins: The Role of Smoking
    Kucuk, Ugur
    Kucuk, Hilal Olgun
    Balta, Sevket
    [J]. ANGIOLOGY, 2013, 64 (07) : 562 - 562
  • [9] Effect of fluvastatin on small dense low density lipoproteins in postmenopausal women with an atherogenic lipoprotein phenotype
    Marz, W
    Scharnagl, H
    Abletshauser, C
    Wieland, H
    Baumstark, M
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 129 - 129
  • [10] Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy
    Rizzo, Manfredi
    Trepp, Roman
    Berneis, Kaspar
    Christ, Emanuel R.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (03) : 361 - 367